🔎 Trials Near Me

Home › B-Cell Lymphoma › California › Los Angeles

B-Cell Lymphoma clinical trials in Los Angeles, CA

6 studies for B-Cell Lymphoma are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

RecruitingPhase 1/2
  • University of Southern California Norris Comprehensive, Los Angeles
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06634589

A Study of ARC-02 in B-cell NHL

RecruitingPhase 1
  • Start Cala, Los Angeles
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT07691606

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

RecruitingPhase 1/2
  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles (UCLA) Medical Center, Los Angeles
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

RecruitingPhase 3
  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles (UCLA), Los Angeles
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07188558

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

RecruitingPhase 1/2
  • Los Angeles Cancer Network, Los Angeles
  • UCLA Medical Center of Hematology/Oncology, Los Angeles
Ages 12 to 95 · All sexes · Updated Apr 15, 2026 · NCT04329728

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
  • Children's Hospital Los Angeles, Los Angeles
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

B-Cell Lymphoma trials in other cities

Other studies in Los Angeles

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.